TGFBR2 and neoplasm: Previous studies have already proved the regulation function of SMAD2, SMAD4, and TGFBR2 in cancers (Matsuzaki et al., 2009; Zhu et al., 2020), and these genes were also found related with miRNAs that strongly correlated with tumor features, indicating the potential function and clinical utility in immunotherapy.